Former Bigfoot Biomedical CEO takes corner office at AI medtech company Q-Bio
October 11, 2024 By Sean Whooley
Former Bigfoot Biomedical CEO Jeffrey Brewer announced on LinkedIn that he started a new role as CEO at Q-Bio. “I’m happy to share that I’ve started a new position as Chief Executive Officer at Q Bio!” Brewer wrote on the social media site. Q-Bio’s website says the company operates “at the intersection of AI, physics and biology.” The company aims to automate the physical exam from data collection to triage and routing. It wants to make preventive personalized healthcare available to everyone.
The company says it’s “making the Star Trek Medbay a reality.” Q-Bio’s Gemini exam combines lab tests, genetics, and vitals with advanced MRI insights. With the exam, plus medical history, wearable and lifestyle data, the company creates a Digital Twin, comprehensively mapping a patient’s health over time.
About Q Bio
Q Bio was founded in 2015 by Jeffrey Kaditz, serial entrepreneur and Founder of Affirm, Dr Michael Snyder, Chair of Genetics and Director of Personalized Medicine and Stanford University, and Dr Garry Choy, physician, radiologist, and former Chief Medical Information Officer at Mass General Hospital. Q Bio is fortunate to be backed by some of the best venture groups in the world including: A16Z, Khosla Ventures, Founders Fund, SciFi VC, and Kevin Durant. This interdisciplinary team based in San Carlos, CA is comprised of pioneers in fields such applied math, computational physics, electrical engineering, genetics, and radiology, hail from a dizzying array of home countries and cultural backgrounds.